Abbott Laboratories (ABT) Non-Current Deferred Tax Liability (2010 - 2014)

Abbott Laboratories has disclosed Non-Current Deferred Tax Liability across 5 years of filings, most recently posting $860.0 million for Q4 2014.

• Non-Current Deferred Tax Liability for Q4 2014 came in at $860.0 million, up 84.55% year-over-year; the trailing twelve-month figure through Dec 2014 was $860.0 million (up 84.55% YoY), and the FY2014 annual result was $860.0 million, up 84.55% from the prior year.
• Non-Current Deferred Tax Liability came in at $860.0 million for Q4 2014 at Abbott Laboratories, up from $466.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 billion in Q4 2010 to a low of $466.0 million in Q4 2013.
• The 5-year median for Non-Current Deferred Tax Liability is $710.0 million (2012), against an average of $770.2 million.
• Across the five-year window, Non-Current Deferred Tax Liability slumped 36.78% in 2011 and jumped 84.55% in 2014, its largest moves.
• Abbott Laboratories' Non-Current Deferred Tax Liability stood at $1.1 billion in 2010, then plunged by 36.78% to $703.0 million in 2011, then grew by 1.0% to $710.0 million in 2012, then plunged by 34.37% to $466.0 million in 2013, then surged by 84.55% to $860.0 million in 2014.
• The last three Non-Current Deferred Tax Liability figures came in at $860.0 million (Q4 2014), $466.0 million (Q4 2013), and $710.0 million (Q4 2012), per Business Quant data.